Cargando…
Augmentation of transforming growth factor-β signaling for the treatment of neurological disorders
Autor principal: | Luo, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154475/ https://www.ncbi.nlm.nih.gov/pubmed/36751787 http://dx.doi.org/10.4103/1673-5374.363833 |
Ejemplares similares
-
Repurposing niclosamide for the treatment of neurological disorders
por: Apolloni, Savina, et al.
Publicado: (2023) -
Glial-derived transforming growth factor β1 (TGF-β1): a key factor in multiple sclerosis neuroinflammation
por: Guevara, Coram, et al.
Publicado: (2020) -
Could mammalian inorganic polyphosphate be a crucial signaling molecule in neurological disorders?
por: Da Costa, Renata Torres, et al.
Publicado: (2023) -
Multi-targeted anti-inflammatory drugs for the treatment of neurological disorders
por: Lui, Austin, et al.
Publicado: (2022) -
Transforming growth factor β1-mediated anti-inflammation slows progression of midbrain dopaminergic neurodegeneration in Parkinson's disease?
por: Spittau, Björn
Publicado: (2015)